{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen", "item": "https://www.patentleaderboard.com/patent/4975369"}]}

Home › Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen

Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen

US Patent 4975369 · Granted Dec 4, 1990

Estimated economic value: $96,957,000 ⓘ

Assignee

Eli Lilly

Inventors

Lisa Selsam Beavers (10 patents)
Thomas F. Bumol (8 patents)
Robert Alan Gadski (11 patents)
Barbara J. Weigel (3 patents)

View full patent text on Google Patents →